Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance
- PMID: 19558268
- DOI: 10.1089/met.2009.0019
Continuous positive airway pressure therapy improves hypoadiponectinemia in severe obese men with obstructive sleep apnea without changes in insulin resistance
Abstract
Background: Obstructive sleep apnea (OSA) is associated with several conditions that could facilitate the onset of cardiovascular and metabolic dysfunctions. Continuous positive airway pressure (CPAP) therapy has been shown to improve cardiovascular morbidity and mortality related to OSA, but the mechanisms underlying this association are not fully understood.
Objective: The aim of the present study was to evaluate whether sleep apnea contributes to insulin resistance and inflammatory marker alterations and to evaluate the benefits of nasal CPAP therapy in severe obese patients with OSA.
Methods: Plasma inflammatory cytokines and the homeostasis model assessment of insulin resistance index (HOMA-IR, Insulin Sensitivity Index [ISI]) were measured in severe obese male with OSA (n = 16) and compared with body mass index (BMI)-matched male controls without OSA (n = 13). Seven patients with severe sleep apnea (apnea-hypopnea index >30 events/h) were reevaluated after 3 months of nasal CPAP therapy.
Results: OSA patients had a significantly lower adiponectin levels than obese controls (8.7 +/- 1.18 ng/mL vs. 15.0 +/- 2.55 ng/mL, P = 0.025). HOMA-IR, ISI, tumor necrosis factor-alpha (TNF-alpha, C-reactive protein (CRP), and interleukin-6 (IL-6) levels were not different between groups. Although insulin resistance index and BMI values did not change after 3 months of nCPAP therapy, adiponectin levels increased (P = 0.036) and the levels of TNF-alpha tended to decrease (P = 0.065). Changes in adiponectin levels during nCPAP therapy were positively correlated with an improvement in minimum oxygen saturation (r = 0.773; P = 0.041) and negatively correlated with changes in TNF-alpha levels (r = -0.885; P = 0.008).
Conclusions: nCPAP therapy reverses hypoadiponectinemia levels present in obese men with OSA, probably through reductions in hypoxia and inflammation activity.
Similar articles
-
Effects of nasal continuous positive airway pressure treatment on oxidative stress and adiponectin levels in obese patients with obstructive sleep apnea.Respiration. 2010;79(5):370-6. doi: 10.1159/000227800. Epub 2009 Jul 3. Respiration. 2010. PMID: 19590157
-
Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance.Clin Endocrinol (Oxf). 2006 Jan;64(1):12-9. doi: 10.1111/j.1365-2265.2005.02407.x. Clin Endocrinol (Oxf). 2006. PMID: 16402923
-
Resistin is closely related to systemic inflammation in obstructive sleep apnea.Respiration. 2008;76(4):377-85. doi: 10.1159/000141866. Epub 2008 Jun 25. Respiration. 2008. PMID: 18577878
-
Sleep apnea is a manifestation of the metabolic syndrome.Sleep Med Rev. 2005 Jun;9(3):211-24. doi: 10.1016/j.smrv.2005.01.006. Sleep Med Rev. 2005. PMID: 15893251 Review.
-
Insulin resistance and other metabolic aspects of the obstructive sleep apnea syndrome.Med Sci Monit. 2005 Mar;11(3):RA70-5. Med Sci Monit. 2005. PMID: 15735578 Review.
Cited by
-
Evaluation of Plasma/Serum Adiponectin (an Anti-Inflammatory Factor) Levels in Adult Patients with Obstructive Sleep Apnea Syndrome: A Systematic Review and Meta-Analysis.Life (Basel). 2022 May 16;12(5):738. doi: 10.3390/life12050738. Life (Basel). 2022. PMID: 35629405 Free PMC article. Review.
-
Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.Pulm Med. 2013;2013:521087. doi: 10.1155/2013/521087. Epub 2013 Jun 27. Pulm Med. 2013. PMID: 23936649 Free PMC article.
-
Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism.Cardiovasc Diabetol. 2010 Dec 1;9:83. doi: 10.1186/1475-2840-9-83. Cardiovasc Diabetol. 2010. PMID: 21122092 Free PMC article.
-
Tumor necrosis factor alpha is a promising circulating biomarker for the development of obstructive sleep apnea syndrome: a meta-analysis.Oncotarget. 2017 Apr 18;8(16):27616-27626. doi: 10.18632/oncotarget.15203. Oncotarget. 2017. PMID: 28187003 Free PMC article. Review.
-
Effect of Continuous Positive Airway Pressure on Adiponectin in Patients with Obstructive Sleep Apnea: A Meta-Analysis.PLoS One. 2015 Sep 14;10(9):e0136837. doi: 10.1371/journal.pone.0136837. eCollection 2015. PLoS One. 2015. PMID: 26367527 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous